These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1531241)

  • 1. Lipoprotein(a). Clinical approach to a unique atherogenic lipoprotein.
    Rader DJ; Brewer HB
    JAMA; 1992 Feb; 267(8):1109-12. PubMed ID: 1531241
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
    Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
    Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing of high-density lipoprotein subfractions and low-density lipoprotein subfractions in human serum with anion-exchange chromatography.
    Hirowatari Y; Tsunoda Y; Ogura Y; Homma Y
    Atherosclerosis; 2009 Jun; 204(2):e52-7. PubMed ID: 19091316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
    Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
    Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of Fasting Triglyceride-Rich Lipoprotein Cholesterol to Coronary Artery Calcium Score (from the ELSA-Brasil Study).
    Bittencourt MS; Santos RD; Staniak H; Sharovsky R; Kondapally R; Vallejo-Vaz AJ; Ray KK; Bensenor I; Lotufo P
    Am J Cardiol; 2017 May; 119(9):1352-1358. PubMed ID: 28302272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.
    Elshazly MB; Nicholls SJ; Nissen SE; St John J; Martin SS; Jones SR; Quispe R; Stegman B; Kapadia SR; Tuzcu EM; Puri R
    Am J Cardiol; 2016 Sep; 118(5):647-55. PubMed ID: 27392507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies.
    Colantonio LD; Bittner V; Reynolds K; Levitan EB; Rosenson RS; Banach M; Kent ST; Derose SF; Zhou H; Safford MM; Muntner P
    Circulation; 2016 Jan; 133(3):256-64. PubMed ID: 26659948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases.
    Nakajima K; Nakajima Y; Takeichi S; Fujita MQ
    Atherosclerosis; 2008 May; 198(1):237-46. PubMed ID: 17977545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
    Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol in coronary artery disease].
    Halilović E; Kabil E; Ljuca F; Nuhbegović S; Berbić S; Halilović E
    Med Arh; 2007; 61(2 Suppl 1):7-10. PubMed ID: 21553440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical factors of coronary atherosclerosis risk].
    Titov VN
    Klin Lab Diagn; 1993; (4):30-7. PubMed ID: 8000789
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoprotein(a) and coronary artery disease: ongoing debate.
    Celik T; Yuksel C; Iyisoy A; Isik E
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):e33-4. PubMed ID: 18472410
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a).
    Süleymanlar G; Ozben T; Sapan M; Yìlmaz H; Yakupoglu G; Karpuzoglu T
    Transplant Proc; 1994 Oct; 26(5):2637-8. PubMed ID: 7940822
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic value of lipids and apolipoproteins for assessment of atherogenic risk].
    Herrmann W; Hanf S; Schütz C; Lindhofer HG; Schmidt H; Strauss HJ; Schaedel H; Oswald B
    Z Gesamte Inn Med; 1988 Feb; 43(4):86-92. PubMed ID: 3376506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.
    Frost PH; Havel RJ
    Am J Cardiol; 1998 Feb; 81(4A):26B-31B. PubMed ID: 9526810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.